Is there a cancer vaccine in sight?

Everyone is talking about RNA as a vaccine. What else can RNA do for drug development in the 21st century?

Dr. Sebastian Kreiter completed his medical studies at Johannes Gutenberg University Mainz in 1997. His clinical training in hematology and oncology (1997-2001) led him to translational science in the field of immunotherapies.

In the academic group of Ugur Sahin and Özlem Türeci, Dr. Kreiter began the preclinical development of in vitro transcribed mRNA cancer vaccination in 2001 and provided basic scientific and technical proof of the concept. He is currently Director of the “Immunotherapy Development Center” at TRON — Translational Oncology at Johannes Gutenberg University Mainz and serves as head of the “Immunotherapy & Preclinical Research” department at BioNTech.

‍